Showing results (161-170 of 203) with videos related to
Sort By:
Pageof 21
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2009
PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccinationAdam C Finnefrock, Aimin Tang, Fengsheng Li, et al.The Journal of Biological Chemistry|October 31, 2014
Derivatives of mesoxalic acid block translocation of HIV-1 reverse transcriptaseJean A Bernatchez, Rakesh Paul, Egor P Tchesnokov, et al.AIDS (London, England)|January 10, 2015
Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapyJosé L Blanco, Julio S G Montaner, Vincent C Marconi, et al.Science Translational Medicine|May 4, 2018
TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapySo-Yon Lim, Christa E Osuna, Peter T Hraber, et al.Journal of Hepatology|December 10, 2017
Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studiesChristophe Hezode, Nancy Reau, Evguenia S Svarovskaia, et al.The Journal of Biological Chemistry|October 9, 2009
Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistanceKalyan Das, Rajiv P Bandwar, Kirsten L White, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 25, 2008
Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort dataBart Winters, Julio Montaner, P Richard Harrigan, et al.Antimicrobial Agents and Chemotherapy|September 1, 2010
Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitorsMing-Tain Lai, Meiqing Lu, Peter J Felock, et al.Proceedings of the National Academy of Sciences of the United States of America|May 21, 2010
Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolatesElisabetta Bianchi, Joseph G Joyce, Michael D Miller, et al.JAMA|April 7, 2011
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysisJonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.Pageof 21